TABLE 1.
Baseline characteristics of the study populationa
| Characteristic | Short course (n = 84), no. (%) | Standard course (n = 87), no. (%) | Total (n = 171), no. (%) |
|---|---|---|---|
| Age | |||
| 6–23 mo | 26 (31) | 30 (34) | 56 (33) |
| 24–71 mo | 58 (69) | 57 (66) | 115 (67) |
| Sex | |||
| Female | 46 (55) | 38 (44) | 84 (49) |
| Male | 38 (45) | 49 (56) | 87 (51) |
| Race | |||
| Asian | 4 (5) | 1 (1) | 5 (3) |
| Black or African American | 19 (23) | 23 (26) | 42 (25) |
| Multiracial | 8 (10) | 4 (5) | 12 (7) |
| White | 51 (61) | 58 (67) | 109 (64) |
| Unknown | 2 (1) | 1 (1) | 3 (2) |
| Ethnicity | |||
| Hispanic or Latino | 8 (10) | 10 (12) | 18 (10) |
| Not Hispanic or Latino | 75 (89) | 77 (88) | 152 (89) |
| Unknown | 1 (1) | 0 (0) | 1 (1) |
| Initial antibiotic | |||
| Amoxicillin | 78 (93) | 78 (90) | 156 (91) |
| Amoxicillin-clavulanate | 4 (5) | 7 (8) | 11 (6) |
| Cefdinir | 2 (2) | 2 (2) | 4 (2) |
a
Data are presented as no. (%) unless otherwise specified. There were no statistically significant differences observed for any of the variables tested when comparing frequencies between the standard and the short treatment strategies (P > 0.05 for each).